Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells
Open Access
- 30 June 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 177 (1), 47-63
- https://doi.org/10.1111/cei.12339
Abstract
Fluorochrome-conjugated peptide-major histocompatibility complex (pMHC) multimers are widely used for flow cytometric visualization of antigen-specific T cells. The most common multimers, streptavidin-biotin-based tetramers', can be manufactured readily in the laboratory. Unfortunately, there are large differences between the threshold of T cell receptor (TCR) affinity required to capture pMHC tetramers from solution and that which is required for T cell activation. This disparity means that tetramers sometimes fail to stain antigen-specific T cells within a sample, an issue that is particularly problematic when staining tumour-specific, autoimmune or MHC class II-restricted T cells, which often display TCRs of low affinity for pMHC. Here, we compared optimized staining with tetramers and dextramers (dextran-based multimers), with the latter carrying greater numbers of both pMHC and fluorochrome per molecule. Most notably, we find that: (i) dextramers stain more brightly than tetramers; (ii) dextramers outperform tetramers when TCR-pMHC affinity is low; (iii) dextramers outperform tetramers with pMHC class II reagents where there is an absence of co-receptor stabilization; and (iv) dextramer sensitivity is enhanced further by specific protein kinase inhibition. Dextramers are compatible with current state-of-the-art flow cytometry platforms and will probably find particular utility in the fields of autoimmunity and cancer immunology.Keywords
Funding Information
- Juvenile Diabetes Research Foundation (17-2012-352)
- UK Department of Health
- King's College London
- Australian National Health and Medical Research (NHMRC) Career Development Fellowship
This publication has 40 references indexed in Scilit:
- Structural basis for the killing of human beta cells by CD8+ T cells in type 1 diabetesNature Immunology, 2012
- Detection of autoreactive CD4 T cells using major histocompatibility complex class II dextramersBMC Immunology, 2011
- Modification of MHC Anchor Residues Generates Heteroclitic Peptides That Alter TCR Binding and T Cell RecognitionThe Journal of Immunology, 2010
- Germ Line-governed Recognition of a Cancer Epitope by an Immunodominant Human T-cell ReceptorJournal of Biological Chemistry, 2009
- Tricks with tetramers: how to get the most from multimeric peptide–MHCImmunology, 2009
- Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramersJournal of Immunological Methods, 2009
- CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitopeJCI Insight, 2008
- Class II major histocompatibility complex tetramer staining: progress, problems, and prospectsImmunology, 2008
- Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant regionEuropean Journal of Immunology, 2007
- CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functionsEuropean Journal of Immunology, 2007